EMP3 has also been reported to show frequent promoter methylation in high-grade astrocytomas and neuroblastomas [32], two tumor entities that display frequent allelic deletions at 19q13.3 [33,34,35]. This evidence concerns the gene EMP3 and astrocytoma (excluding glioblastoma).